MeSH term
Frequency | Condition_Probility | Adult | 8 | 0.0 |
Aged | 6 | 0.0 |
Chromosome Deletion | 2 | 0.0 |
Comparative Study | 7 | 0.0 |
DNA Mutational Analysis | 2 | 0.0 |
DNA, Neoplasm/genetics | 2 | 0.0 |
Female | 25 | 0.0 |
Gene Amplification/genetics | 2 | 3.0 |
Humans | 91 | 0.0 |
Male | 17 | 0.0 |
Middle Aged | 9 | 0.0 |
Nucleic Acid Hybridization | 2 | 0.0 |
Research Support, Non-U.S. Gov't | 75 | 0.0 |
Animals | 39 | 0.0 |
Breast Neoplasms/enzymology/pathology | 2 | 25.0 |
Enzyme Induction | 2 | 0.0 |
Mice | 25 | 0.0 |
Protein-Serine-Threonine Kinases/*physiology | 4 | 3.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 14 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 53 | 0.0 |
Signal Transduction/physiology | 4 | 0.0 |
Tumor Cells, Cultured | 27 | 0.0 |
Cells, Cultured | 12 | 0.0 |
Disease Models, Animal | 2 | 0.0 |
Mice, Inbred C57BL | 3 | 0.0 |
Protein-Serine-Threonine Kinases/genetics/*metabolism | 6 | 2.0 |
*Proto-Oncogene Proteins | 28 | 1.0 |
Rabbits | 2 | 0.0 |
Signal Transduction | 14 | 0.0 |
Apoptosis | 8 | 0.0 |
Cell Line | 18 | 0.0 |
JNK Mitogen-Activated Protein Kinases | 3 | 0.0 |
NF-kappa B/*metabolism | 4 | 0.0 |
Phosphorylation | 27 | 0.0 |
Precipitin Tests | 11 | 0.0 |
Protein-Serine-Threonine Kinases/metabolism | 9 | 1.0 |
Ultraviolet Rays | 3 | 0.0 |
p38 Mitogen-Activated Protein Kinases | 4 | 0.0 |
Cell Survival/physiology | 6 | 3.0 |
*Protein-Serine-Threonine Kinases | 27 | 3.0 |
Recombinant Proteins/pharmacology | 2 | 0.0 |
Base Sequence | 8 | 0.0 |
Binding Sites | 3 | 0.0 |
Cell Differentiation | 2 | 0.0 |
Cloning, Molecular | 7 | 0.0 |
Molecular Sequence Data | 6 | 0.0 |
Proto-Oncogene Proteins/*genetics | 4 | 0.0 |
Trans-Activation (Genetics) | 4 | 0.0 |
Enzyme Activation | 15 | 0.0 |
Glioblastoma/genetics/metabolism/*pathology | 2 | 40.0 |
*MAP Kinase Kinase Kinase 1 | 2 | 1.0 |
Drug Resistance, Neoplasm | 6 | 1.0 |
Phenotype | 3 | 0.0 |
Protein-Tyrosine Kinase | 2 | 5.0 |
Reverse Transcriptase Polymerase Chain Reaction | 11 | 0.0 |
1-Phosphatidylinositol 3-Kinase/physiology | 2 | 1.0 |
Cell Cycle | 2 | 0.0 |
Cell Survival | 7 | 0.0 |
Gene Amplification | 3 | 0.0 |
Models, Biological | 2 | 0.0 |
Protein Structure, Tertiary | 5 | 0.0 |
Proto-Oncogene Proteins/chemistry/genetics/*physiology | 2 | 20.0 |
*Signal Transduction | 6 | 0.0 |
MAP Kinase Signaling System | 3 | 1.0 |
Protein-Serine-Threonine Kinases/physiology | 2 | 2.0 |
Ribosomal Protein S6 Kinases/physiology | 2 | 25.0 |
*Arabidopsis Proteins | 3 | 3.0 |
Mice, Transgenic | 2 | 0.0 |
Polymerase Chain Reaction | 6 | 0.0 |
Reference Values | 2 | 0.0 |
1-Phosphatidylinositol 3-Kinase/metabolism | 8 | 1.0 |
Blotting, Western | 16 | 0.0 |
DNA-Binding Proteins/*metabolism | 2 | 0.0 |
Electrophoresis, Polyacrylamide Gel | 2 | 0.0 |
Hamsters | 2 | 0.0 |
Hypoglycemic Agents/*pharmacology | 2 | 4.0 |
Insulin/*pharmacology | 3 | 1.0 |
Microscopy, Fluorescence | 3 | 0.0 |
NF-kappa B/metabolism | 3 | 0.0 |
Ubiquitin/metabolism | 3 | 1.0 |
Tyrphostins/pharmacology | 2 | 1.0 |
Recombinant Fusion Proteins/genetics/metabolism | 3 | 0.0 |
Signal Transduction/drug effects | 4 | 0.0 |
1-Phosphatidylinositol 3-Kinase/antagonists & inhibitors/metabolism | 6 | 6.0 |
Antineoplastic Agents/*pharmacology | 3 | 0.0 |
Apoptosis/drug effects | 3 | 0.0 |
Cell Division/drug effects | 6 | 0.0 |
Cell Line, Tumor | 5 | 0.0 |
Down-Regulation | 5 | 0.0 |
Gene Expression Regulation, Enzymologic | 4 | 0.0 |
Hela Cells | 5 | 0.0 |
Protein-Serine-Threonine Kinases/biosynthesis/genetics/*metabolism | 2 | 28.0 |
DNA Primers | 6 | 0.0 |
*Gene Expression Regulation, Enzymologic | 2 | 0.0 |
Kinetics | 4 | 0.0 |
Protein Binding | 6 | 0.0 |
*Proto-Oncogenes | 2 | 0.0 |
Recombinant Fusion Proteins/metabolism | 4 | 0.0 |
Restriction Mapping | 2 | 0.0 |
Transfection | 14 | 0.0 |
Antineoplastic Agents/pharmacology | 2 | 0.0 |
*Apoptosis | 3 | 0.0 |
Caspases/metabolism | 4 | 0.0 |
Flow Cytometry | 2 | 0.0 |
Oligonucleotides, Antisense/pharmacology | 2 | 0.0 |
Protein-Serine-Threonine Kinases/*metabolism | 7 | 1.0 |
Exons | 2 | 0.0 |
Introns | 2 | 0.0 |
Linkage Disequilibrium | 2 | 0.0 |
Protein-Serine-Threonine Kinases/*genetics | 3 | 1.0 |
3T3 Cells | 4 | 0.0 |
*Cell Transformation, Neoplastic | 4 | 0.0 |
Immunohistochemistry | 4 | 0.0 |
Mutation | 7 | 0.0 |
Protein Transport | 3 | 0.0 |
Protein-Tyrosine Kinase/physiology | 2 | 1.0 |
Mitogen-Activated Protein Kinases/metabolism | 5 | 0.0 |
Jurkat Cells | 2 | 0.0 |
Sequence Alignment | 2 | 0.0 |
Sequence Homology, Amino Acid | 2 | 0.0 |
1-Phosphatidylinositol 3-Kinase/*metabolism | 6 | 2.0 |
Proto-Oncogene Proteins/*metabolism | 9 | 0.0 |
Rats | 9 | 0.0 |
Chromones/pharmacology | 10 | 4.0 |
Enzyme Activation/drug effects | 2 | 0.0 |
Morpholines/pharmacology | 10 | 4.0 |
*Muscle Proteins | 2 | 0.0 |
Mutation/genetics | 2 | 0.0 |
Phosphorylation/drug effects | 3 | 0.0 |
Proto-Oncogene Proteins/genetics/*metabolism | 8 | 2.0 |
Sirolimus/pharmacology | 2 | 2.0 |
DNA, Recombinant | 2 | 1.0 |
Neoplasm Invasiveness | 3 | 0.0 |
Phosphoric Monoester Hydrolases/metabolism | 2 | 2.0 |
Plasmids/genetics | 2 | 0.0 |
Up-Regulation | 2 | 0.0 |
Apoptosis/*drug effects | 3 | 0.0 |
Flavonoids/pharmacology | 2 | 0.0 |
Hepatocyte Growth Factor/*pharmacology | 2 | 1.0 |
Ligands | 3 | 0.0 |
Enzyme Inhibitors/pharmacology | 10 | 0.0 |
Androstadienes/pharmacology | 2 | 0.0 |
Blotting, Southern | 4 | 0.0 |
Protein Isoforms | 3 | 0.0 |
Serine/metabolism | 3 | 0.0 |
Time Factors | 6 | 0.0 |
Biological Transport | 3 | 0.0 |
*Gene Expression Regulation, Neoplastic | 5 | 0.0 |
Genes, Tumor Suppressor | 2 | 0.0 |
In Situ Hybridization, Fluorescence | 3 | 0.0 |
Protein Biosynthesis | 2 | 0.0 |
RNA, Messenger/genetics | 2 | 0.0 |
Transcription, Genetic | 2 | 0.0 |
Mitogen-Activated Protein Kinase 3 | 3 | 0.0 |
Mitogen-Activated Protein Kinase 8 | 2 | 2.0 |
Mitogen-Activated Protein Kinases/*metabolism | 2 | 0.0 |
Amino Acid Sequence | 4 | 0.0 |
Protein-Serine-Threonine Kinases/chemistry/genetics/*metabolism | 2 | 4.0 |
*Oncogenes | 2 | 0.0 |
Cell Division | 4 | 0.0 |
Cell Membrane/enzymology | 2 | 0.0 |
Retroviridae/genetics | 2 | 0.0 |
MAP Kinase Kinase 1 | 2 | 1.0 |
Amino Acid Chloromethyl Ketones/pharmacology | 2 | 1.0 |
Serine/chemistry | 3 | 2.0 |
Threonine/chemistry | 2 | 2.0 |
Estrogen Receptor alpha | 2 | 0.0 |
Mitogen-Activated Protein Kinase 1/metabolism | 2 | 0.0 |
Proto-Oncogene Proteins c-bcl-2/metabolism | 4 | 0.0 |
Apoptosis/drug effects/*physiology | 3 | 1.0 |
Proto-Oncogene Proteins/*physiology | 2 | 0.0 |
Immunoblotting | 6 | 0.0 |
Alleles | 2 | 0.0 |
Cyclins/metabolism | 2 | 0.0 |
Mice, Nude | 3 | 0.0 |
Proto-Oncogene Proteins/metabolism | 2 | 0.0 |
DNA, Neoplasm/*genetics | 2 | 0.0 |
*Gene Amplification | 2 | 0.0 |
Combined Modality Therapy | 2 | 0.0 |
Dose-Response Relationship, Drug | 5 | 0.0 |
Rifabutin/*analogs & derivatives/*pharmacology | 2 | 18.0 |
Xenograft Model Antitumor Assays | 2 | 0.0 |
Breast Neoplasms/genetics/*pathology | 2 | 4.0 |
Cell Adhesion | 2 | 0.0 |
Gene Expression Regulation, Neoplastic | 4 | 0.0 |
Adolescent | 3 | 0.0 |
Aged, 80 and over | 2 | 0.0 |
Child | 2 | 0.0 |
DNA/analysis | 2 | 0.0 |
Signal Transduction/*physiology | 2 | 0.0 |
Glutathione Transferase/metabolism | 3 | 0.0 |
Plasmids/metabolism | 4 | 0.0 |
Oligonucleotide Array Sequence Analysis | 4 | 0.0 |
Gene Deletion | 2 | 0.0 |
Mice, Knockout | 3 | 0.0 |
Recombinant Proteins/metabolism | 3 | 0.0 |
Tumor Necrosis Factor-alpha/pharmacology | 2 | 0.0 |
Rats, Sprague-Dawley | 2 | 0.0 |
Growth Substances/metabolism | 2 | 1.0 |
Fibroblasts/metabolism | 2 | 0.0 |
Insulin/*metabolism | 2 | 2.0 |
Genetic Vectors | 3 | 0.0 |
Trans-Activators/metabolism | 2 | 0.0 |
Transcription Factors/*metabolism | 2 | 0.0 |
*Adaptor Proteins, Signal Transducing | 2 | 0.0 |
Insulin-Like Growth Factor I/metabolism | 2 | 1.0 |
DNA, Complementary/metabolism | 2 | 0.0 |
Proto-Oncogene Proteins c-myc/metabolism | 2 | 2.0 |
*Genes, erbB-2 | 3 | 3.0 |
HL-60 Cells | 2 | 0.0 |
Protein p53/metabolism | 2 | 0.0 |
Enzyme-Linked Immunosorbent Assay | 2 | 0.0 |
Proteins/metabolism | 2 | 0.0 |
